Catch up with top Healio Dermatology news from August

Key takeaways:

• In the top story of August, Healio spoke with an expert on the risks of “baby Botox” following Simone Bile’s poor experience.
• Nutrition-based articles also dominated the month’s headlines.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

In case you missed any of these stories, here are the top articles from last month.

Q&A: Expert discusses risks of baby Botox as Simone Biles shares side effects

Following Simone Biles’ poor experience with “baby Botox,” David Hill, MD, a plastic surgeon and co-founder and medical director of Fulcrum Aesthetics & Surgery, spoke with Healio about the risks of these cosmetic procedures. Read more.

Vegan nutraceutical increases hair growth in plant-based diets

Researchers found that patients who followed a plant-based diet experienced hair growth with the addition of a daily vegan nutraceutical. Read more.

Q&A: Expert discusses causes of vitiligo as Kim Kardashian opens up about son’s diagnosis

With Kim Kardashian speaking out about her son’s experience with vitiligo, Healio Dermatology sat with John E. Harris, MD, PhD, founding director of the Vitiligo Clinic and Research Center and of the Autoimmune Therapeutics Institute, to discuss the condition in the adult and pediatric populations. Read more.

Chocolate consumption could intensify acne lesions

Even with an anti-inflammatory diet, the consumption of chocolate correlated with an increase in acne lesions. Read more.

Abdominal skin aging reduced with carboxytherapy

Abdominal skin treated with carboxytherapy showed a significant increase in epidermal and dermal thickness. Read more.

FDA approves pediatric indication for NexoBrid for treatment of thermal burns

On Aug. 20, the FDA approved a pediatric indication for NexoBrid for the treatment of deep partial-thickness and full-thickness thermal burns. Read more.

Isotretinoin prescribers frustrated with stalled iPledge modifications

As of July, it has been 9 months since the FDA released recommended changes to the iPledge Risk Evaluation and Mitigation Strategy and providers have grown increasingly frustrated at a perceived lack of transparency and implementation plan. In this feature, Healio spoke with multiple experts, including John S. Barbieri, MD, MBA, assistant professor at Harvard Medical School, director of the advanced acne therapeutics clinic at Brigham and Women’s Hospital and co-chair of the AAD’s iPledge workgroup, about this issue. Read more.

Dermatologists play significant role in detecting, addressing body dysmorphic disorder

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder. Read more.

Q&A: Appropriately sized instruments needed for female surgeon

Despite women comprising 36% of physicians currently working in the medical field, surgical instruments have long been standardized for men’s hands, which causes challenges. To raise awareness of this issue, Healio spoke with Lara Devgan, MD, MPH, FACS, an attending plastic surgeon at Lenox Hill Hospital, Greenwich Hospital and Manhattan Eye, Ear & Throat Infirmary, chief medical officer of RealSelf and CEO of Dr. Devgan Scientific Beauty, which created a line of plastic surgery instruments for women. Read more.

Gene signature predicts severe adverse events from ICI therapy for melanoma

Lastly, a new study identified a gene signature that can predict which group of patients with melanoma will experience severe immune-related adverse events when treated with immune checkpoint inhibitor therapy. Read more.